Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

3.5%

11 terminated/withdrawn out of 315 trials

Success Rate

96.1%

+9.6% vs industry average

Late-Stage Pipeline

46%

145 trials in Phase 3/4

Results Transparency

75%

205 of 273 completed trials have results

Key Signals

11 recruiting205 with results7 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

97(32.8%)

Phase 4

76(25.7%)

Phase 3

69(23.3%)

Phase 2

40(13.5%)

Phase 1

13(4.4%)

Early Phase 1

1(0.3%)

296Total

N/A(97)

Phase 4(76)

Phase 3(69)

Phase 2(40)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (315)

Showing 20 of 315 trials

NCT07566286Not ApplicableNot Yet Recruiting

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Role: lead

NCT03713203Not ApplicableRecruiting

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).

Role: collaborator

NCT05622851Not ApplicableCompleted

Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers

Role: lead

NCT05075408Phase 2Completed

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

Role: lead

NCT02511145Phase 1Completed

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Role: lead

NCT07074977Phase 2Recruiting

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Role: lead

NCT03417856Enrolling By Invitation

Defining the Skin and Blood Biomarkers of Ichthyosis

Role: collaborator

NCT05620043Not ApplicableCompleted

Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler

Role: lead

NCT06351358Not ApplicableCompleted

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Role: lead

NCT07398989Phase 4Completed

A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin

Role: lead

NCT07047690Phase 2Recruiting

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Role: lead

NCT04275999Phase 2Completed

Rosacea and Ivermectin

Role: collaborator

NCT06988605Recruiting

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Role: lead

NCT07047638Not ApplicableActive Not Recruiting

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine

Role: lead

NCT06988618Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Role: lead

NCT07399028Not ApplicableRecruiting

A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging

Role: lead

NCT06351293Not ApplicableCompleted

A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction

Role: lead

NCT07344584Not ApplicableNot Yet Recruiting

A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area

Role: lead

NCT07342400Not ApplicableRecruiting

A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages

Role: lead

NCT04341623Not ApplicableActive Not Recruiting

Xerosis and Use of Topical Moisturizer

Role: collaborator